138 related articles for article (PubMed ID: 23907567)
1. Peroxiredoxins, thioredoxin, and Y-box-binding protein-1 are involved in the pathogenesis and progression of dialysis-associated renal cell carcinoma.
Fushimi F; Taguchi K; Izumi H; Kohno K; Kuwano M; Ono M; Nakashima Y; Takesue T; Naito S; Oda Y
Virchows Arch; 2013 Oct; 463(4):553-62. PubMed ID: 23907567
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress and DNA hypermethylation status in renal cell carcinoma arising in patients on dialysis.
Hori Y; Oda Y; Kiyoshima K; Yamada Y; Nakashima Y; Naito S; Tsuneyoshi M
J Pathol; 2007 Jun; 212(2):218-26. PubMed ID: 17451187
[TBL] [Abstract][Full Text] [Related]
3. Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma.
Soini Y; Kallio JP; Hirvikoski P; Helin H; Kellokumpu-Lehtinen P; Kang SW; Tammela TL; Peltoniemi M; Martikainen PM; Kinnula VL
APMIS; 2006 May; 114(5):329-37. PubMed ID: 16725008
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.
Tickoo SK; dePeralta-Venturina MN; Harik LR; Worcester HD; Salama ME; Young AN; Moch H; Amin MB
Am J Surg Pathol; 2006 Feb; 30(2):141-53. PubMed ID: 16434887
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features and CD57 expression in renal cell carcinoma in acquired cystic disease of the kidneys: with special emphasis on a relation to the duration of haemodialysis, the degree of calcium oxalate deposition, histological type, and possible tumorigenesis.
Enoki Y; Katoh G; Okabe H; Yanagisawa A
Histopathology; 2010 Feb; 56(3):384-94. PubMed ID: 20459538
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas.
Wang Y; Chen Y; Geng H; Qi C; Liu Y; Yue D
Tumour Biol; 2015 Sep; 36(9):7159-66. PubMed ID: 25877750
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
8. Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study.
Kondo T; Sasa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
Pathol Int; 2018 Oct; 68(10):543-549. PubMed ID: 30187581
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis.
Nouh MA; Kuroda N; Yamashita M; Hayashida Y; Yano T; Minakuchi J; Taniguchi S; Nomura I; Inui M; Sugimoto M; Kakehi Y
BJU Int; 2010 Mar; 105(5):620-7. PubMed ID: 19747356
[TBL] [Abstract][Full Text] [Related]
10. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACD-RCC): A Multiinstitutional Study of 40 Cases With Clinical Follow-up.
Przybycin CG; Harper HL; Reynolds JP; Magi-Galluzzi C; Nguyen JK; Wu A; Sangoi AR; Liu PS; Umar S; Mehra R; Zhang X; Cox RM; McKenney JK
Am J Surg Pathol; 2018 Sep; 42(9):1156-1165. PubMed ID: 29851703
[TBL] [Abstract][Full Text] [Related]
11. [Acquired renal cystic disease].
Kawamura K; Ikeda R; Suzuki K
Hinyokika Kiyo; 2000 Sep; 46(9):651-6. PubMed ID: 11107538
[TBL] [Abstract][Full Text] [Related]
12. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
[TBL] [Abstract][Full Text] [Related]
13. Renal neoplasias in patients receiving dialysis and renal transplantation: clinico-pathological features and p53 gene mutations.
Hoshida Y; Nakanishi H; Shin M; Satoh T; Hanai J; Aozasa K
Transplantation; 1999 Aug; 68(3):385-90. PubMed ID: 10459542
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Clinicopathologic Analyses of Acquired Cystic Disease-associated Renal Cell Carcinoma With Focus on Adverse Prognostic Factors and Metastatic Lesions.
Kojima F; Gandhi JS; Matsuzaki I; Iba A; Collier S; Yoshikawa T; Kinoshita Y; Warigaya K; Fujimoto M; Kuroda N; Morii E; Hara I; Murata SI; Amin MB
Am J Surg Pathol; 2020 Aug; 44(8):1031-1039. PubMed ID: 32271189
[TBL] [Abstract][Full Text] [Related]
15. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
[TBL] [Abstract][Full Text] [Related]
16. Klotho suppresses tumor progression via inhibiting PI3K/Akt/GSK3β/Snail signaling in renal cell carcinoma.
Zhu Y; Xu L; Zhang J; Xu W; Liu Y; Yin H; Lv T; An H; Liu L; He H; Zhang H; Liu J; Xu J; Lin Z
Cancer Sci; 2013 Jun; 104(6):663-71. PubMed ID: 23433103
[TBL] [Abstract][Full Text] [Related]
17. Acquired cystic disease of kidney associated with renal cell carcinoma in chronic dialysis patients.
Lin JI; Saklayen M; Ehrenpresis M; Hillman NM
Urology; 1992 Feb; 39(2):190-3. PubMed ID: 1736519
[TBL] [Abstract][Full Text] [Related]
18. Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung.
Park JH; Kim YS; Lee HL; Shim JY; Lee KS; Oh YJ; Shin SS; Choi YH; Park KJ; Park RW; Hwang SC
Respirology; 2006 May; 11(3):269-75. PubMed ID: 16635084
[TBL] [Abstract][Full Text] [Related]
19. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
[TBL] [Abstract][Full Text] [Related]
20. Holliday junction‑recognition protein modulates apoptosis, cell cycle arrest and reactive oxygen species stress in human renal cell carcinoma.
Yuan JS; Chen ZS; Wang K; Zhang ZL
Oncol Rep; 2020 Sep; 44(3):1246-1254. PubMed ID: 32582972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
